CLARIANT CHEMICALS (INDIA) LTD. (CLNINDIA) fair value: what the stock is really worth
As of Oct 1, 2026: fair value of CLARIANT CHEMICALS (INDIA) LTD. ₹92.20, price ₹365, upside -74.8%, quality 62 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch CLARIANT CHEMICALS (INDIA) LTD. for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range ₹261.40 – ₹674.40 · fair‑value band ₹87.32 – ₹100.11 · the ₹365.15 price screens above the ₹92.20 fair value. Dashed = 300-day average. As of Sep 24, 2026.
Follow CLARIANT CHEMICALS (INDIA) in your weekly email
Every Wednesday you see whether CLARIANT CHEMICALS (INDIA) is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
CLARIANT CHEMICALS (INDIA) LTD. (CLNINDIA) currently trades at ₹365.15, while our model-based Fair Value estimate is ₹92.20, 74.8% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of ₹308.81 per share, and 0 of the 15 models we run sit above the ₹365.15 price.
Bear case: the Earnings-Based group reads lowest at ₹104.74, and 15 of the 15 models stay below the price. Evidence for this calculation is low.
Scenario range: ₹87.32 (bear) to ₹100.11 (bull), the price of ₹365.15 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 62/100 (solid quality), in the Materials sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
CLARIANT CHEMICALS (INDIA) LTD. reported revenue of ₹8.3B in FY2022 versus ₹10.1B in FY2019, a compound −6.4%/yr. Reported net income was ₹433M in FY2022, compounding +32.6%/yr from FY2019.
Key figures
Market cap ₹8.4B (≈ $87.5M) · P/E ratio 17.0 · P/S ratio 0.89 · Dividend yield 3.0% · Net margin 5.2% · Return on assets (EBIT) 4.7% · Free cash flow −₹70.0M.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 47 out of 100 (medium confidence).
What moves the price
The share trades about 32% below its 52-week high and 34% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Materials peers we cover trades at −39% fair-value upside, at −75%, CLNINDIA screens richer than that median.
Fair Value models
Bear ₹87.32Fair Value ₹92.20Bull ₹100.11
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.12/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
+15.5%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−6.4%
’19
’20
’21
’22
What shareholders gained per year (last 3 years), in INR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 3 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in INR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+10.7%
Earnings growth per share plus dividend.
Earnings per share, growth per year+7.7%
Dividend (yield on the price)3.0%
Profit margin 2019 to 2022 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.2% → 5%
Compare CLARIANT CHEMICALS (INDIA) LTD. with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 709 stocks
Beats the industry median on 4/8 measures
A mixed picture versus its industry peers.
Valuation
Quality Score62 · Top 25%
Fair Value upside−74.8% · Bottom 25%
Profitability
Return on assets0.0% · Bottom 25%
Net margin (TTM)5.2% · Above median
Operating margin (TTM)0.0% · Bottom 25%
Growth and dividend
Revenue growth0.0% · Below median
Dividend yield (TTM)3.0% · Top 25%
Valuation Multiplesvs Specialty Chemicals median · lower = cheaper
P/E (TTM)17.0× · Cheaper than median
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 0
FUTURE (revenue growth)0· sector 44
PAST (return on equity)0· sector 25
HEALTH (low debt)0· sector 95
DIVIDEND (yield)60· sector 29
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is CLARIANT CHEMICALS (INDIA) LTD. (CLNINDIA) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of ₹92.20 versus a price of ₹365.15, about −75% upside (overvalued).
What is the fair value of CLNINDIA?
Our model-based fair value for CLARIANT CHEMICALS (INDIA) LTD. is ₹92.20 (as of Sep 24, 2026), built from audited fundamentals. The current price: ₹365.15.
What is the quality score of CLNINDIA?
CLARIANT CHEMICALS (INDIA) LTD. has a Quality Score of 62/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for CLARIANT CHEMICALS (INDIA) LTD. (CLNINDIA)?
Our model-based price target is the fair value of ₹92.20 (as of Sep 24, 2026) from 15 valuation models. Cautious scenario ₹87.32, optimistic scenario ₹100.11. It is a calculation from audited fundamentals, not an analyst target.
What is the CLARIANT CHEMICALS (INDIA) LTD. stock forecast for 2026?
Our models put fair value at ₹92.20, about −75% upside versus a price of ₹365.15 (overvalued). Cautious scenario ₹87.32, optimistic scenario ₹100.11. The calculation is refreshed regularly with new filings.
Does CLARIANT CHEMICALS (INDIA) LTD. pay a dividend?
CLARIANT CHEMICALS (INDIA) LTD. currently shows a dividend yield of about 3.01% relative to its recent price (as of Sep 24, 2026).
What is the intrinsic value of CLARIANT CHEMICALS (INDIA) LTD. (CLNINDIA)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For CLARIANT CHEMICALS (INDIA) LTD. it is ₹92.20 per share (as of Sep 24, 2026), against a price of ₹365.15. It is the blended result of 15 valuation models (cash flow, earnings, asset, dividend).
Is CLARIANT CHEMICALS (INDIA) LTD. stock overvalued or undervalued in 2026?
As of Sep 24, 2026, CLNINDIA trades above its calculated fair value: price ₹365.15, fair value ₹92.20, a gap of about −75% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of CLNINDIA?
No. The price is what the market pays today (₹365.15); the fair value is what the company's own numbers justify (₹92.20). For CLARIANT CHEMICALS (INDIA) LTD. the two are ₹272.95 per share apart. That gap is exactly why we show both numbers side by side.
How much is CLARIANT CHEMICALS (INDIA) LTD. worth?
The market values CLARIANT CHEMICALS (INDIA) LTD. at about ₹8.4B (market capitalisation, as of Sep 24, 2026). Per share that is ₹365.15; our models calculate a fair value of ₹92.20 per share.
What do the bullish and bearish scenarios say about CLNINDIA?
Our models span a range for CLARIANT CHEMICALS (INDIA) LTD.: cautious scenario ₹87.32, base ₹92.20, optimistic ₹100.11 per share (as of Sep 24, 2026, price ₹365.15). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of CLNINDIA?
CLARIANT CHEMICALS (INDIA) LTD. trades at a price-to-earnings ratio of 17.0 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹92.20 is built from several models across several years.
How far is CLNINDIA from its 52-week high?
CLARIANT CHEMICALS (INDIA) LTD. trades at ₹365.15, about 32% below its 52-week high of ₹540.40 and 34% above the low of ₹272.95 (as of Oct 1, 2026). Distance from the high says nothing about value: that is what the fair value of ₹92.20 is for.
Which stocks are comparable to CLARIANT CHEMICALS (INDIA) LTD.?
From the same area (Materials) we also value Linde plc, The Sherwin-Williams Company, Ecolab Inc, Air Products and Chemicals, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is CLARIANT CHEMICALS (INDIA) LTD. stock attractive at the current price?
The data as of Sep 24, 2026: price ₹365.15, calculated fair value ₹92.20 (−75%), Quality Score 62/100, from 15 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of CLNINDIA calculated?
We run CLARIANT CHEMICALS (INDIA) LTD. through 15 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ₹92.20, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. CLARIANT CHEMICALS (INDIA) LTD. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of CLARIANT CHEMICALS (INDIA) LTD. (CLNINDIA)?
The closing price on Oct 1, 2026 was ₹365.15. Our model-based fair value is ₹92.20, about −75% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with CLARIANT CHEMICALS (INDIA) LTD. right now?
The price sits above even our optimistic bull case (₹100.11). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (62/100) and above fair value, neither a clear bargain nor a standout compounder. The models converge in a tight band (₹87.32 to ₹100.11), unusually little disagreement for a valuation.
Key figures of CLARIANT CHEMICALS (INDIA) LTD.
How large is the market capitalisation of CLARIANT CHEMICALS (INDIA) LTD. (CLNINDIA)?
The market capitalisation of CLARIANT CHEMICALS (INDIA) LTD. is ₹8.4B (≈ $87.5M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of CLARIANT CHEMICALS (INDIA) LTD. (CLNINDIA)?
The price-to-sales ratio of CLARIANT CHEMICALS (INDIA) LTD. is 0.89 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the dividend yield of CLARIANT CHEMICALS (INDIA) LTD. (CLNINDIA)?
The dividend yield of CLARIANT CHEMICALS (INDIA) LTD. is 3.0%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of CLARIANT CHEMICALS (INDIA) LTD. (CLNINDIA)?
The net margin of CLARIANT CHEMICALS (INDIA) LTD. is 5.2% (fiscal year 2022). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the EBIT return on assets of CLARIANT CHEMICALS (INDIA) LTD. (CLNINDIA)?
On an EBIT basis the return on assets of CLARIANT CHEMICALS (INDIA) LTD. is 4.7% (avg 4y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
How much free cash flow does CLARIANT CHEMICALS (INDIA) LTD. (CLNINDIA) generate?
The free cash flow of CLARIANT CHEMICALS (INDIA) LTD. is −₹70.0M (fiscal year 2022). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
Free · no account needed
Watch CLARIANT CHEMICALS (INDIA) LTD. in the live analysis
One click puts CLARIANT CHEMICALS (INDIA) LTD. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
